A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Mild to Moderate Pneumonia in Adult Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

468

Participants

Timeline

Start Date

April 30, 2003

Study Completion Date

April 30, 2004

Conditions
Pneumonia
Interventions
DRUG

azithromycin sustained release

azithromycin SR 2.0 g by mouth in the form of a slurry for 1 dose

OTHER

placebo

placebo

DRUG

levofloxacin

500 mg (two 250 mg capsules) by mouth once daily for 7 days

OTHER

placebo

placebo

Trial Locations (65)

19067

Pfizer Investigational Site, Morrisville

19335

Pfizer Investigational Site, Downingtown

19406

Pfizer Investigational Site, King of Prussia

19702

Pfizer Investigational Site, Newark

21502

Pfizer Investigational Site, Cumberland

28209

Pfizer Investigational Site, Charlotte

28210

Pfizer Investigational Site, Charlotte

28262

Pfizer Investigational Site, Charlotte

28601

Pfizer Investigational Site, Hickory

29651

Pfizer Investigational Site, Greer

32953

Pfizer Investigational Site, Merrit Island

34741

Pfizer Investigational Site, Kissimmee

38024

Pfizer Investigational Site, Dyersburg

38654

Pfizer Investigational Site, Olive Branch

42431

Pfizer Investigational Site, Madisonville

46254

Pfizer Investigational Site, Indianapolis

47712

Pfizer Investigational Site, Evansville

47714

Pfizer Investigational Site, Evansville

49009

Pfizer Investigational Site, Kalamazoo

52001

Pfizer Investigational Site, Dubuque

53051

Pfizer Investigational Site, Menomonee Falls

64460

Pfizer Investigational Site, Monterrey

67124

Pfizer Investigational Site, Pratt

68022

Pfizer Investigational Site, Elkhorn

68144

Pfizer Investigational Site, Omaha

73099

Pfizer Investigational Site, Yukon

77566

Pfizer Investigational Site, Lake Jackson

80130

Pfizer Investigational Site, Highlands Ranch

84109

Pfizer Investigational Site, Salt Lake City

84121

Pfizer Investigational Site, Salt Lake City

85014

Pfizer Investigational Site, Phoenix

85206

Pfizer Investigational Site, Mesa

87124

Pfizer Investigational Site, Rio Rancho

93401

Pfizer Investigational Site, San Luis Obispo

94403

Pfizer Investigational Site, San Mateo

99362

Pfizer Investigational Site, Walla Walla

105077

Pfizer Investigational Site, Moscow

105229

Pfizer Investigational Site, Moscow

107066

Pfizer Investigational Site, Moscow

119048

Pfizer Investigational Site, Moscow

214019

Pfizer Investigational Site, Smolensk

560052

Pfizer Investigational Site, Bangalore

560054

Pfizer Investigational Site, Bangalore

600116

Pfizer Investigational Site, Chennai

632002

Pfizer Investigational Site, Vellore

V3A 4H9

Pfizer Investigational Site, Langley

K6A 1A1

Pfizer Investigational Site, Hawkesbury

N2C 2N9

Pfizer Investigational Site, Kitchener

M9W 4L6

Pfizer Investigational Site, Toronto

H3H 1V4

Pfizer Investigational Site, Montreal

H9R 4S3

Pfizer Investigational Site, Pointe-Claire

G1V 4P9

Pfizer Investigational Site, Ste-foy

G6P 6N2

Pfizer Investigational Site, Victoriaville

S9A 0V6

Pfizer Investigational Site, North Battleford

S7K 7H9

Pfizer Investigational Site, Saskatoon

Unknown

Pfizer Investigational Site, Providencia

Pfizer Investigational Site, Indore

Pfizer Investigational Site, Nagpur

Pfizer Investigational Site, San Isidro

Pfizer Investigational Site, San Miguel

Pfizer Investigational Site, Moscow

400 012

Pfizer Investigational Site, Mumbai

LT-4580

Pfizer Investigational Site, Alytus

LT-3021

Pfizer Investigational Site, Kaunas

LT-5800

Pfizer Investigational Site, Klaipėda

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00643734 - A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Mild to Moderate Pneumonia in Adult Patients | Biotech Hunter | Biotech Hunter